Tier 2 Canada Research Chair in Anticoagulant Treatment of Cardiovascular Disease Hematologist
The Ottawa Hospital
Dr. Deborah Siegal MD MSc FRCPC is an Associate Professor of Medicine at the University of Ottawa and Associate Scientist at the Ottawa Hospital Research Institute. She holds a Tier 2 Canada Research Chair in Anticoagulant Treatment of Cardiovascular Disease. She received MSc degrees in Pharmacology and Health Research Methodology.
Her primary research interests include (i) optimizing the acute management of anticoagulant-related bleeding and the role of anticoagulant reversal, (ii) developing an evidence-based strategy for restarting anticoagulants after bleeding, (iii), understanding patient and physician decision-making after anticoagulant-related bleeding, (iv) management of anticoagulated patients who require urgent surgery, (v) treatments and outcomes of ischemic stroke in patients with cancer.
She holds peer-reviewed grants from the Canadian Institutes of Health Research, CanVECTOR/Heart and Stroke Foundation of Canada, American Society of Hematology and Ontario Foundation for Innovation.
She has published over 100 peer-reviewed articles including high-impact journals such the New England Journal of Medicine, Circulation, Annals of Internal Medicine, Canadian Medical Association Journal, Blood and Journal of Thrombosis and Haemostasis.
Sunday, July 10, 2022
12:30 PM – 1:00 PM
Sunday, July 10, 2022
4:55 PM – 5:05 PM
Sunday, July 10, 2022
6:30 PM – 7:30 PM
Monday, July 11, 2022
6:30 PM – 7:30 PM
Tuesday, July 12, 2022
8:40 AM – 9:00 AM
Tuesday, July 12, 2022
1:15 PM – 1:25 PM
Tuesday, July 12, 2022
2:05 PM – 2:20 PM
Tuesday, July 12, 2022
2:20 PM – 2:30 PM